NeuroGyn develops neurostimulation systems and minimally invasive neuromodulation procedures for treating pelvic and systemic disorders.
Neurogyn Ag has raised $4.8M in total funding. The most recent round was Series A. The last funding was announced in October 2026.
Neurogyn Ag is headquartered in Risch, Switzerland.
NeuroGyn develops neurostimulation systems and minimally invasive neuromodulation procedures for treating pelvic and systemic disorders.
Neurogyn Ag is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurogyn Ag — Funding & Investors." VCBacked, October 13, 2026, https://www.vcbacked.co/company/neurogyn-ag. Accessed November 2, 2026.
VCBacked. (2026). Neurogyn Ag — Funding & Investors. Retrieved November 2, 2026, from https://www.vcbacked.co/company/neurogyn-ag
{{cite web |title=Neurogyn Ag — Funding & Investors |url=https://www.vcbacked.co/company/neurogyn-ag |website=VCBacked |access-date=November 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated